Business Description
Assembly Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US0453961080
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 55.61 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.17 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -61.2 | |||||
3-Year EBITDA Growth Rate | 13.6 | |||||
3-Year EPS without NRI Growth Rate | 14 | |||||
3-Year Book Growth Rate | -55.5 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.59 | |||||
9-Day RSI | 47.1 | |||||
14-Day RSI | 47.83 | |||||
6-1 Month Momentum % | 60.21 | |||||
12-1 Month Momentum % | 17.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.41 | |||||
Quick Ratio | 3.41 | |||||
Cash Ratio | 3.32 | |||||
Days Sales Outstanding | 26.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.6 | |||||
Shareholder Yield % | -14.92 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -902.5 | |||||
Net Margin % | -854.78 | |||||
FCF Margin % | 210.86 | |||||
ROE % | -105.29 | |||||
ROA % | -69.59 | |||||
ROIC % | -413.51 | |||||
ROC (Joel Greenblatt) % | -2435.98 | |||||
ROCE % | -90.17 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 6.08 | |||||
PS Ratio | 9.96 | |||||
PB Ratio | 1.79 | |||||
Price-to-Tangible-Book | 1.79 | |||||
Price-to-Free-Cash-Flow | 6.58 | |||||
Price-to-Operating-Cash-Flow | 6.58 | |||||
EV-to-EBIT | 0.84 | |||||
EV-to-EBITDA | 0.85 | |||||
EV-to-Revenue | -7.6 | |||||
EV-to-FCF | -2.39 | |||||
Price-to-Net-Current-Asset-Value | 1.93 | |||||
Price-to-Net-Cash | 2.13 | |||||
Earnings Yield (Greenblatt) % | 119.05 | |||||
FCF Yield % | 30.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Assembly Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 11.89 | ||
EPS (TTM) (€) | -9.703 | ||
Beta | 1 | ||
Volatility % | 40.65 | ||
14-Day RSI | 47.83 | ||
14-Day ATR (€) | 0.483626 | ||
20-Day SMA (€) | 12.4835 | ||
12-1 Month Momentum % | 17.75 | ||
52-Week Range (€) | 7.092 - 19.128 | ||
Shares Outstanding (Mil) | 5.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Assembly Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Assembly Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Assembly Biosciences Inc Frequently Asked Questions
What is Assembly Biosciences Inc(FRA:V7B)'s stock price today?
When is next earnings date of Assembly Biosciences Inc(FRA:V7B)?
Does Assembly Biosciences Inc(FRA:V7B) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |